Cargando…

Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma

PURPOSE: Several miRNAs have been reported as candidate oncogenes and tumor suppressors, which are involved in the pathways specifically altered during tumorigenesis or metastasis. The miR 17–92 cluster located in 13q31 locus might contribute to retinoblastoma (RB) oncogenesis as 13q31 is amplified...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandalam, Moutushy Mitra, Beta, Madhu, Maheswari, Uma K., Swaminathan, S., Krishnakumar, Subramanian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436882/
https://www.ncbi.nlm.nih.gov/pubmed/22969266
_version_ 1782242718881153024
author Kandalam, Moutushy Mitra
Beta, Madhu
Maheswari, Uma K.
Swaminathan, S.
Krishnakumar, Subramanian
author_facet Kandalam, Moutushy Mitra
Beta, Madhu
Maheswari, Uma K.
Swaminathan, S.
Krishnakumar, Subramanian
author_sort Kandalam, Moutushy Mitra
collection PubMed
description PURPOSE: Several miRNAs have been reported as candidate oncogenes and tumor suppressors, which are involved in the pathways specifically altered during tumorigenesis or metastasis. The miR 17–92 cluster located in 13q31 locus might contribute to retinoblastoma (RB) oncogenesis as 13q31 is amplified often in RB. We attempted to identify the factors involved in the regulation of miR 17–92 cluster in RB. METHODS: Real-time quantitative reverse transcriptase PCR was performed to study the expression of the miR 17–92 cluster in primary RB tumors and in Y79 cells after epithelial cell adhesion molecule (EpCAM) silencing. EpCAM was silenced using siRNA and confirmed by western blotting. The Y79 cells were transfected with individual and mixed antagomirs and studied the cell viability by (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, invasion by matrigel analysis and caspase-3 expression by flow cytometry. RESULTS: The relative expression of miR 17–92 cluster, compared to that of a normal retina, ranged from 25 to 220 fold (p<0.0001), miR-18 being highly expressed in RB. Post EpCAM silencing resulted in a significant decrease (p<0.01) in the expression of the miR 17–92 cluster by 4 to eightfold in Y79 cells. Y79 cells transfected with an antagomirs mix (all 5 miRNAs) showed decreased cell viability (p<0.001) and cell invasion (p<0.001). Similarly, Y79 cells treated with antagomirs mix showed increased expression of caspase-3 (p<0.001), which confirms the anti-proliferative effect of antagomirs. CONCLUSIONS: This study has showed varied expression of the miR17–92 cluster in primary RB tumors. EpCAM influences miR 17–92 cluster expression in retinoblastoma. In addition, we showed that the miR 17–92 cluster plays a role in RB cell proliferation and invasion. Therefore, targeting the miRNA 17–92 cluster may be beneficial for controlling Y79/RB cell proliferation and invasion.
format Online
Article
Text
id pubmed-3436882
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-34368822012-09-11 Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma Kandalam, Moutushy Mitra Beta, Madhu Maheswari, Uma K. Swaminathan, S. Krishnakumar, Subramanian Mol Vis Research Article PURPOSE: Several miRNAs have been reported as candidate oncogenes and tumor suppressors, which are involved in the pathways specifically altered during tumorigenesis or metastasis. The miR 17–92 cluster located in 13q31 locus might contribute to retinoblastoma (RB) oncogenesis as 13q31 is amplified often in RB. We attempted to identify the factors involved in the regulation of miR 17–92 cluster in RB. METHODS: Real-time quantitative reverse transcriptase PCR was performed to study the expression of the miR 17–92 cluster in primary RB tumors and in Y79 cells after epithelial cell adhesion molecule (EpCAM) silencing. EpCAM was silenced using siRNA and confirmed by western blotting. The Y79 cells were transfected with individual and mixed antagomirs and studied the cell viability by (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, invasion by matrigel analysis and caspase-3 expression by flow cytometry. RESULTS: The relative expression of miR 17–92 cluster, compared to that of a normal retina, ranged from 25 to 220 fold (p<0.0001), miR-18 being highly expressed in RB. Post EpCAM silencing resulted in a significant decrease (p<0.01) in the expression of the miR 17–92 cluster by 4 to eightfold in Y79 cells. Y79 cells transfected with an antagomirs mix (all 5 miRNAs) showed decreased cell viability (p<0.001) and cell invasion (p<0.001). Similarly, Y79 cells treated with antagomirs mix showed increased expression of caspase-3 (p<0.001), which confirms the anti-proliferative effect of antagomirs. CONCLUSIONS: This study has showed varied expression of the miR17–92 cluster in primary RB tumors. EpCAM influences miR 17–92 cluster expression in retinoblastoma. In addition, we showed that the miR 17–92 cluster plays a role in RB cell proliferation and invasion. Therefore, targeting the miRNA 17–92 cluster may be beneficial for controlling Y79/RB cell proliferation and invasion. Molecular Vision 2012-08-28 /pmc/articles/PMC3436882/ /pubmed/22969266 Text en Copyright © 2012 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kandalam, Moutushy Mitra
Beta, Madhu
Maheswari, Uma K.
Swaminathan, S.
Krishnakumar, Subramanian
Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title_full Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title_fullStr Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title_full_unstemmed Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title_short Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
title_sort oncogenic microrna 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436882/
https://www.ncbi.nlm.nih.gov/pubmed/22969266
work_keys_str_mv AT kandalammoutushymitra oncogenicmicrorna1792clusterisregulatedbyepithelialcelladhesionmoleculeandcouldbeapotentialtherapeutictargetinretinoblastoma
AT betamadhu oncogenicmicrorna1792clusterisregulatedbyepithelialcelladhesionmoleculeandcouldbeapotentialtherapeutictargetinretinoblastoma
AT maheswariumak oncogenicmicrorna1792clusterisregulatedbyepithelialcelladhesionmoleculeandcouldbeapotentialtherapeutictargetinretinoblastoma
AT swaminathans oncogenicmicrorna1792clusterisregulatedbyepithelialcelladhesionmoleculeandcouldbeapotentialtherapeutictargetinretinoblastoma
AT krishnakumarsubramanian oncogenicmicrorna1792clusterisregulatedbyepithelialcelladhesionmoleculeandcouldbeapotentialtherapeutictargetinretinoblastoma